The mission of the Georgetown University Memory Disorders Program is to prevent and treat Alzheimer's disease and related dementias by conducting innovative research, educating and training healthcare professionals and the public on research advances, and offering state-of-the-art clinical care.
WE ARE ON FACEBOOK
"Like" our facebook page to stay up to date on research findings and helpful information
JOIN OUR MAILING LIST!
Would you like to receive our Fall newsletter? Sign up here to receive our newsletter either in the mail or via email. We send out two newsletters a year to everyone on our mailing list and as well invitations to our yearly fall appreciation event.
Here are our research studies that are currently recruiting patients.
|Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss (A4)||ADCS/ Eli Lilly and Company|
Efficacy and Safety of Aducanumab (BIIB037) in Subjects with Early Alzheimer's Disease *enrolling in MCI cohort only*
|ATRI and Yale University|
|Eli Lilly & Co|
Check out our Research section for more information on how to participate in our clinical trials.
Make a Donation
For information about how to make a tax-deductible contribution to the Memory Disorders Program, please click here.